You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xcellerated T Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

Not yet recruiting
  • Multiple Myeloma
  • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
  • +3 more
  • (no location specified)
Jul 28, 2023

Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

Recruiting
  • Pancreatic Cancer
  • TCR-T Cells Injection（GB3010 Cells Injection）
  • ShangHai, Shanghai, China
    Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

Recruiting
  • Multiple Myeloma in Remission
  • MM-specific universal CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Aug 23, 2023

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

Not yet recruiting
  • Relapsed Acute Myeloid Leukaemia
  • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
  • (no location specified)
Jul 4, 2023

TINO: T Cells in the Nose of Older Adults

Recruiting
  • Respiratory Tract Infections
  • Aging
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Center
    Sep 8, 2023

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)

    Not yet recruiting
    • Glioblastoma
    • +3 more
    • CARv3-TEAM-E T cells
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Dec 13, 2022

    Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Anti-CD33 CAR T-cells
    • Lymphodepletion Therapy
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

    Not yet recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Apr 5, 2023

    EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV Infection After Allogenic HSCT
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 3, 2023

    Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)

    Recruiting
    • Multiple Myeloma
    • Immune System Diseases
    • CAR138 T Cells
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Jan 10, 2023

    T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

    Recruiting
    • T Lymphoblastic Leukemia/Lymphoma
    • CD7 CAR-T cells
    • Shenzhen, Guangdong, China
      Li Yu
    Nov 11, 2022

    Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)

    Not yet recruiting
    • Advanced Solid Tumor
    • αPD1-MSLN-CAR T Cells
    • Beijing, China
      National Cancer Center Cancer Hospital Chinese Academy of Medica
    Jul 13, 2023

    Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

    Recruiting
    • Diffuse Large B-cell Lymphoma
    • Metabolically Armed CD19 CAR-T cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Nov 1, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Autologous Mesothelin-specific TCR-T Cells
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 31, 2023

    Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

    Active, not recruiting
    • Leukemia
    • Acute Lymphoblastic Leukemia
    • gene-modified T cells targeted
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 1, 2023

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

    Recruiting
    • Multiple Myeloma
    • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 11, 2023

    Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    • Sarcoma
    • Autologous HER2-specific T cells
    • +3 more
    • Houston, Texas
    • +1 more
    Nov 21, 2022

    Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023

    Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

    Recruiting
    • Pancreas Cancer
    • +3 more
    • CAR-T cells
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Mar 10, 2023

    T-bet B Cells in Persistent Virus Control After Discontinuance

    Completed
    • Chronic HBV Infection
    • Drug Withdrawal
    • T-bet B cell
    • Shanghai, China
      Changhai hospital
    Sep 1, 2023